BridgeBio Pharma Inc (BBIO) is near the middle in its sector according to InvestorsObserver.
BBIO gets an overall rating of 84. That means it scores higher than 84% of stocks.
BridgeBio Pharma Inc gets a 49 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 84 means the stock is more attractive than 84 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.
These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With BridgeBio Pharma Inc Stock Today?
BridgeBio Pharma Inc (BBIO) stock is trading at $39.70 as of 1:57 PM on Tuesday, Sep 22, a rise of $0.04, or 0.1% from the previous closing price of $39.66. Volume today is light. So far 251,900 shares have traded compared to average volume of 603,046 shares. The stock has traded between $37.99 and $39.97 so far today.
Click Here to get the full Stock Score Report on BridgeBio Pharma Inc (BBIO) Stock.
